期刊文献+

注射用益气复脉治疗慢性阻塞性肺疾病急性加重期并呼吸衰竭的疗效观察 被引量:20

Investigation of injection Yiqifumai on the treatment of chronic obstructive pulmonary disease with respiratory failure
暂未订购
导出
摘要 目的观察注射用益气复脉(冻干)治疗慢性阻塞性肺疾病急性加重期并呼吸衰竭的临床疗效。方法将60例慢性阻塞性肺疾病急性加重期并呼吸衰竭患者随机分为2组,对照组30例,给予常规治疗;治疗组30例,在对照组基础上加用注射用益气复脉(冻干),每次8瓶(每瓶0.65g用5 mL注射用水溶解),加入5%葡萄糖注射液250 mL稀释后静脉滴注,每日1次,2周1个疗程。观察2组治疗前后临床症状及血气指标的变化。结果 2组治疗后临床症状(咳嗽、气喘、肺部干湿性啰音)及血气指标与治疗前比较差异均有统计学意义(P<0.05),治疗组改善程度优于对照组。结论注射用益气复脉(冻干)明显改善慢性阻塞性肺疾病急性加重期并呼吸衰竭的临床症状,改善血气各项指标。 Objective To investigate the effect of injection Yiqifumai on the treatment of chronic obstructive pulmonary disease with respiratory failure.Methods 60 patients with chronic obstructive pulmonary disease with respiratory failure were randomly divided into two groups.30 cases in control group were given with the routine treatment;30 cases in treatment group were given control group's routine treatment combined with injection Yiqifumai(freeze-dried) 8 bottles(0.65 g/bottle with 5 mL injection water solution),add in 250 mL 5 % glucose diluted intravenous drip,once a day.Clinical symptoms and the changes in blood gas were observed before and after treatment.Results There were significant differences between two groups on clinical symptoms(cough,asthma and pulmonary rales) and blood gas index after treatment(P0.05).The improvement of the treatment group was superior to that in control group.Conclusion Injection Yiqifumai(freeze-dried) can obviously improve the clinical symptoms of chronic obstructive pulmonary disease with respiratory failure,improve blood gas index,shorten the days in hospital patients.
出处 《河北中医》 2012年第2期261-263,共3页 Hebei Journal of Traditional Chinese Medicine
基金 2009年邢台市科学技术研究与发展指导计划(第一批)项目(编号:2009SP091)
关键词 补气剂 肺疾病 阻塞性 慢性病 呼吸功能不全 中西医结合疗法 Tonifying qi agent Pulmonary disease Chronic obstructive Respiratory insufficiency Integrated traditional Chinese medicine and western medicine therapy
  • 相关文献

参考文献5

二级参考文献49

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:280
  • 2王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:91
  • 3GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
  • 4Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
  • 5Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.
  • 6冉丕鑫 王辰 姚婉贞 等.我国部分地区慢性阻塞性肺疾病流行病学研究[J].中华结核和呼吸杂志,2007,.
  • 7Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
  • 8Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
  • 9Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
  • 10Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.

共引文献11993

同被引文献334

引证文献20

二级引证文献204

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部